Endometriosis and uterine fibroids (leiomyomata) : comorbidity, risks and implications
Uimari, Outi; Nazri, Hannah; Tapmeier, Thomas (2021-10-26)
Uimari O, Nazri H and Tapmeier T (2021) Endometriosis and Uterine Fibroids (Leiomyomata): Comorbidity, Risks and Implications. Front. Reprod. Health 3:750018. doi: 10.3389/frph.2021.750018
© 2021 Uimari, Nazri and Tapmeier. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
https://creativecommons.org/licenses/by/4.0/
https://urn.fi/URN:NBN:fi-fe202301102140
Tiivistelmä
Abstract
Uterine Fibroids (leiomyomata) and endometriosis affect millions of women world-wide. Although aetiology and natural history of the conditions are markedly different, symptoms can overlap and make differential diagnoses necessary, often using invasive methods such as laparoscopy. Considerable comorbidity exists between the two conditions and needs to be taken into account when treating fibroids and/or endometriosis. The genetic foundations of both uterine fibroids and endometriosis remain to be fully understood but recent evidence suggest common underpinnings. Here, we discuss the comorbidity of uterine fibroids and endometriosis and the implications for diagnosis, treatment and risks.
Kokoelmat
- Avoin saatavuus [31657]